Attached files

file filename
S-1 - REGISTRATION STATEMENT - SOLIGENIX, INC.fs10416_soligenix.htm
EX-23.1 - CONSENT OF EISNERAMPER LLP - SOLIGENIX, INC.fs10416ex23i_soligenix.htm

EXHIBIT 21.1

 

SUBSIDIARIES OF SOLIGENIX, INC.

 

The following represents a list of Soligenix, Inc.’s subsidiaries:

 

Name  Ownership   State of Incorporation
Enteron Pharmaceuticals, Inc.   100.00%  Delaware
Orasomal Technologies Inc.   75.30%  Delaware
DOR BioDefense Corp.   100.00%  Delaware
Soligenix BioPharma Canada Incorporated   100.00%  Canada
Soligenix UK Limited   100.00%  United Kingdom